Barclays Downgrades Vitamin Shoppe (VSI) to Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow on course for slim gains at open as Iran tensions clash with AI optimism
- Oil prices fall after hitting over one-month high; traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Vitamin Shoppe (VSI) PT Bumped to $42 at Piper Jaffray Following In-Line Q4
February 25, 2015 7:51 AM ESTPiper Jaffray analyst Sean Naughton bumped his price target on Vitamin Shoppe (NYSE: VSI) to $42.00 (from $40.00) following Q4 results but maintained a Neutral rating.
Naughton commented, "This morning Vitamin Shoppe announced Q4 EPS that was in-line with expectations as better margins helped to... More
Vitamin Shoppe (VSI) Reports In-Line Q4 EPS
February 24, 2015 6:06 AM ESTVitamin Shoppe (NYSE: VSI) reported Q4 EPS of $0.41, in-line with the analyst estimate of $0.41. Revenue for the quarter came in at $290.1 million versus the consensus estimate of $294.77 million.
Total comparable sales grew 2.1%.
Vitamin Shoppe sees FY2015 EPS of $2.36-$2.46, versus the consensus of... More
